Chengcheng Wang

Title: Chengcheng Wang: Innovator in Anti-CD4 Antibodies

Introduction

Chengcheng Wang is a notable inventor based in Taicang, China. He has made significant contributions to the field of biotechnology, particularly in the development of anti-CD4 antibodies. His work has implications for various therapeutic applications, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Chengcheng Wang holds 1 patent related to anti-CD4 antibodies. The patent provides a detailed disclosure of anti-CD4 antibodies or antigen-binding fragments, isolated polynucleotides encoding these antibodies, pharmaceutical compositions that include them, and their various uses. This invention represents a crucial step in the development of targeted therapies.

Career Highlights

Chengcheng Wang is currently employed at Crown Bioscience Inc., a company known for its focus on preclinical research and development services. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Chengcheng has worked alongside talented colleagues, including Ziyong Sun and Wencui Ma. Their collaborative efforts enhance the research environment and foster innovation within their projects.

Conclusion

Chengcheng Wang's contributions to the field of biotechnology, particularly through his patent on anti-CD4 antibodies, highlight his role as an innovator. His work at Crown Bioscience Inc. and collaborations with esteemed colleagues further emphasize his commitment to advancing medical research.